DNLI — DENALI THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  18 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in DENALI THERAPEUTICS INC (DNLI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2019 Q1)
Avg. % of fund
0.01%
First filed
2019 Q1
Last filed
2025 Q3
Quarters held
18
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 80,518 -606,633 -88.3% 0.00% $1.2M $14.52
2025 Q1 ADDED 687,151 +638,532 +1313.3% 0.01% $9.3M $13.60
2024 Q4 ADDED 48,619 +14,896 +44.2% 0.00% $991K $20.38
2024 Q3 REDUCED 33,723 -89,957 -72.7% 0.00% $982K $29.13
14 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    DNLI price (monthly, adj. close)

Other funds also holding DNLI

As of 2025 Q4 — sorted by position size

Crestline Management, LP 3Y 7Y 87.02% Lynx1 Capital Management LP 3Y 5.81% Casdin Capital, LLC 3Y 7Y 1.89% Palo Alto Investors LP 3Y 7Y 1.47% DAFNA Capital Management LLC 3Y 7Y 1.22% STEMPOINT CAPITAL LP 1.19% Monashee Investment Management LLC 3Y 7Y 0.85% Siren, L.L.C. 0.69% MASTERS CAPITAL MANAGEMENT LLC 3Y 7Y 0.67% PSP Research LLC 0.46%
← Back to Squarepoint Ops LLC Holdings